Extensive cross-reactivity of adenovirus-specific cytotoxic T cells

Human Gene Therapy

Volumn 9, Issue 10, 1998, Pages 1419-1427

  Smith, Colton A ^a   Woodruff, Linda S ^a   Rooney, Cliona ^a   Kitchingman, Geoffrey R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CLONING VECTOR; CROSS REACTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; GENE THERAPY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; NONHUMAN; RAT; SEROTYPE; TRANSGENE;

EID: 0032127610     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.10-1419     Document Type: Article

References (6)

1. ARMENTANO, D., SOOKDEO, C.C., HEHIR, K.M., GREGORY, R.J., ST. GEORGE, J.A., PRINCE, G.A., WADSWORTH, S.C., and SMITH, A.E. (1995). Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum. Gene Ther. 6, 1343-1353.
2. BEIER, D.C., COX, J.H., VINING, D.R., CRESSWELL, P., and ENGELHARD, V.H. (1994). Association of human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol. 304, 3862-3871.
3. BETT, A.J., PREVEC, L. and GRAHAM, F.L. (1993). Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67, 5911-5921.
4. BETT, A., HADDARA, W., PREVEC, L., and GRAHAM, F.L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. U.S.A. 91, 8802-8806.
5. BURROWS, S.R., KHANNA, R., BURROWS, J.M., and MOSS, D.J. (1994). An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with single Epstein-Barr virus CTL epitope: Implications for graft-versus-host disease. J. Exp. Med. 179, 1155-1161.
6. CHRIST, M., LUSKY, M., STOECKEL, F., DREYER, D., DIETERLE, A., MICHOU, A.I., PAVIRANI, A., and MEHTALI, M. (1997). Gene therapy with recombinant adenovirus vectors: Evaluation of the host immune response. Immunol. Lett. 57, 19-25.